C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
PremiumThe FlyC4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
20d ago
C4 Therapeutics announces next steps for CFT1946
Premium
The Fly
C4 Therapeutics announces next steps for CFT1946
2M ago
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
Premium
The Fly
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
2M ago
C4 Therapeutics reports Q2 EPS (26c) , consensus (37c)
PremiumThe FlyC4 Therapeutics reports Q2 EPS (26c) , consensus (37c)
3M ago
C4 Therapeutics Appoints Mr. Cooper to Board
Premium
Company Announcements
C4 Therapeutics Appoints Mr. Cooper to Board
5M ago
C4 Therapeutics appoints Cooper as Chairman of Board of Directors
Premium
The Fly
C4 Therapeutics appoints Cooper as Chairman of Board of Directors
5M ago
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
PremiumThe FlyJPMorgan biotech/pharma analysts hold an analyst/industry conference call
8M ago
C4 Therapeutics Initiates Stock Option Repricing for Retention
Premium
Company Announcements
C4 Therapeutics Initiates Stock Option Repricing for Retention
8M ago
C4 Therapeutics Strikes Major Oncology Deal with Merck KGaA
Premium
Company Announcements
C4 Therapeutics Strikes Major Oncology Deal with Merck KGaA
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100